Bloody Bar 30K Triple Twist E-cigarette Launched in UK with 3 * "2+10" Design

Jan.07.2025
Bloody Bar 30K Triple Twist E-cigarette Launched in UK with 3 * "2+10" Design
UK introduces new Bloody Bar 30K Triple Twist e-cigarette with unique pod design and multiple flavor options.

Special announcement:

This article is for internal industry communication only and does not make any recommendations for brands or products.

The images presented in this article are for descriptive purposes only and are not intended as advertisements for any products.

This article is prohibited for minors to access.


 

UK e-cigarette market have launched a new e-cigarette - the Bloody Bar 30K Triple Twist. This product features a unique design that combines 3 "2+10" combinations, offering triple flavors and 30,000 puffs.

 

Bloody Bar 30K Triple Twist E-cigarette Launched in UK with 3 *
Translation: Bloody Bar 30K Triple Twist|Image source: goldenvape

 

 

Specifically, the product specifications of the Bloody Bar 30K Triple Twist are as shown in the table below.

Bloody Bar 30K Triple Twist E-cigarette Launched in UK with 3 *
Bloody Bar 30K Triple Twist Parameters | Design: 2Firsts

The key feature of the Bloody Bar 30K Triple Twist is its unique pod design. This e-cigarette device comes with three "2+10" pods, each with a total e-liquid capacity of 36 milliliters. Additionally, each pod can be filled with a different e-liquid flavor, allowing for quick flavor changes through a rotating mechanism.

 

Previously, Bloody Bar released a 2-in-1 e-cigarette called the Bloody Bar Ultra Twist 20K, which is capable of providing two different flavors at the same time. Users can easily switch between flavors by rotating the mouthpiece.

 

Bloody Bar 30K Triple Twist E-cigarette Launched in UK with 3 *
Public Notice | Image Source: MHRA

 

It is worth noting that the UK's Medicines and Healthcare products Regulatory Agency (MHRA) e-cigarette notification system shows that "BLOODY BAR TRIPLE TWIST 30K" was publicly announced in November 2024. The applicant is BOWMAN SPECIALISED LIQUIDS LIMITED, founded by Christopher Bowman in 2012, a company focused on research and sales of e-cigarette e-liquids.

 

Bloody Bar 30K Triple Twist E-cigarette Launched in UK with 3 *
BOWMAN SPECIALISED LIQUIDS LIMITED Website | Image source: BOWMAN

 

Currently, the Bloody Bar 30K Triple Twist has been listed on various UK e-cigarette distributor websites such as vapesourcing, ecigone, and vapeuk, with a price of approximately £12.99. However, the product has not yet been made available for sale on the company's official website.

 

Bloody Bar 30K Triple Twist E-cigarette Launched in UK with 3 *
Blood Bar 30K Triple Twist | Image source: vapesourcing

 


2Firsts will continue to monitor the performance and market trends of e-cigarette products globally, providing accurate and authoritative industry information to the public.

 

2FIRSTS, a product column, is dedicated to providing readers with the latest information on new products in the tobacco industry. To gather and share first-hand industry information more widely, 2FIRSTS welcomes readers to submit articles and share the latest products in the e-cigarette field with us.

 

If you have any unique insights or information, please feel free to contact us anytime via email at info@2firsts.com.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
JTI Liggett Puts U.S. Value Cigarette Brands in Spotlight at 2026 NACS Show
JTI Liggett Puts U.S. Value Cigarette Brands in Spotlight at 2026 NACS Show
At the 2026 NACS Show in Las Vegas, JTI Liggett highlighted its value-priced cigarette portfolio, including LD and Montego, following JT Group's acquisition of Vector Group. The company's U.S. business reported market share gains, with LD sales volume rising 32.6% in the first half of 2026. Meanwhile, Ploom was displayed separately at Altria's booth under an existing partnership. JTI Liggett booth staff told 2Firsts that the company had not yet launched nicotine pouch products in the United States.
EXPO
Oct.09
UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
The UK Insolvency Service said YSK Enterprises imported large quantities of vapes from China in 2023, with a shipment addressed to the company declared as medical nebulizers before Border Force found 352,688 vaping products. HMRC calculated nearly £15 million ($20.3 million) in unpaid VAT and customs duty, alongside about £437,000 in corporation tax. Two directors were disqualified for nine years. The case predates the UK's Vaping Products Duty, which will introduce vape-specific excise and duty-stamp requirements from October 2026.
Regulations
Sep.11
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26
As Regulators Focus on Nicotine Pouch Child Safety, Safeguard Pursues an External Packaging Route
As Regulators Focus on Nicotine Pouch Child Safety, Safeguard Pursues an External Packaging Route
As regulators pay closer attention to child safety in nicotine pouches, manufacturers face a practical challenge: how to strengthen child-resistant packaging without unnecessarily reworking products, production lines and regulatory submissions already in place. In a written interview with 2Firsts, Chemular detailed Safeguard’s external packaging approach, its customer-specific testing requirements and possible PMTA pathways. The model remains early-stage, but it offers a new way to think about an increasingly important regulatory and manufacturing issue.
Industry Insight
Sep.19